S. A. ÖZKAN And N. KARADAŞ BAKIRHAN, "Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode," Euroanalysis 2017 , Sweden, 2017
ÖZKAN, S. A. And KARADAŞ BAKIRHAN, N. 2017. Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode. Euroanalysis 2017 , (Sweden).
ÖZKAN, S. A., & KARADAŞ BAKIRHAN, N., (2017). Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode . Euroanalysis 2017, Sweden
ÖZKAN, SİBEL, And NURGÜL KARADAŞ BAKIRHAN. "Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode," Euroanalysis 2017, Sweden, 2017
ÖZKAN, SİBEL A. And KARADAŞ BAKIRHAN, NURGÜL K. . "Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode." Euroanalysis 2017 , Sweden, 2017
ÖZKAN, S. A. And KARADAŞ BAKIRHAN, N. (2017) . "Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode." Euroanalysis 2017 , Sweden.
@conferencepaper{conferencepaper, author={SİBEL AYŞIL ÖZKAN And author={NURGÜL KARADAŞ BAKIRHAN}, title={Enhanced Host-Guest Detection of Non-small Cell Lung Cancer Drug: Erlotinib Hydrochloride Via beta-Cyclodextrin Particles Modified Glassy Carbon Electrode}, congress name={Euroanalysis 2017}, city={}, country={Sweden}, year={2017}}